The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study

This trial is registered and authorized on December 21st, 2023 in EU Clinical Trials with registration number 2023-505430-10-00.

Authors

Institutions

Publication Details

Journal
Alzheimer s Research & Therapy
Published
2024-10-19
DOI
https://doi.org/10.1186/s13195-024-01588-4
Citations
4
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
1.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study

Marie R. Vermeiren, Meike Willemijn Vernooij, Argonde C. van Harten, Leonie N.C. Visser et al.
4 citations
Alzheimer s Research & Therapy
Dementia and Cognitive Impairment Research
1.54
article

The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study

Marie R. Vermeiren, Meike Willemijn Vernooij, Argonde C. van Harten, Leonie N.C. Visser, Joost F. Somsen, Rik Ossenkoppele, Geert Jan Biessels, Afina W. Lemstra, Wiesje M. van der Flier, Emma M. Coomans, Liesbeth Hempenius, Elsmarieke van de Giessen, Harro Seelaar, J. Matthijs Biesbroek, Gert Luurtsema, Fransje E. Reesink, Sophie E. M. Veldhuijzen van Zanten, Charlotte Elisabeth Teunissen, Nelleke Tolboom, Nicolaas A. Verwey
article en
4 citations

Abstract

This trial is registered and authorized on December 21st, 2023 in EU Clinical Trials with registration number 2023-505430-10-00.

Alzheimer s Research & TherapyVol. 16(1)
Netherlands Institute for Neuroscience (NL), University Medical Center Groningen (NL), University of Groningen (NL), Lund University (SE), Erasmus MC (NL), Medisch Centrum Leeuwarden (NL), Karolinska Institutet (SE), University Medical Center Utrecht (NL), Diakonessenhuis hospital (NL), Amsterdam Neuroscience (NL), Amsterdam University Medical Centers (NL), Vrije Universiteit Amsterdam (NL), University of Amsterdam (NL)
ZonMw, Alzheimer Nederland, Amsterdam Neuroscience, Avid Radiopharmaceuticals
Reduced inequalities
Openalex Percentile: Top 16%
Dementia and Cognitive Impairment Research
1.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.